Fanny Duval

Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial

Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf et al. · The Lancet Neurology · 2021 · 169 citations · Full text

Late-onset Pompe Disease, Autoimmune Disease, Clinical Infectious Disease +3

Glial Fibrillary Acidic Protein Autoimmunity

Alice Gravier-Dumonceau, Roxana Améli, Véronique Rogemond et al. · Neurology · 2021 · 135 citations · Full text

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

Guillaume Manson, Alexandre Maria, F. Poizeau et al. · Journal for ImmunoTherapy of Cancer · 2019 · 102 citations · Full text

Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis

Guilhem Solé, Stéphane Mathis, Diane Friedman et al. · Neurology · 2021 · 56 citations

Cholic acid as a treatment for cerebrotendinous xanthomatosis in adults

Daniele Mandia, Annabelle Chaussenot, Gérard Besson et al. · Journal of Neurology · 2019 · 52 citations

Medicine, Pathology, Cholic Acid